3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
2
Esophageal Neoplasms
2
Squamous-Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Liver Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Colonic Neoplasms
1
Biliary Tract Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
Sorafenib
9
Radiofrequency Ablation
7
Oxaliplatin
7
Fluorouracil
6
Doxorubicin
6
Neoadjuvant Therapy
5
toripalimab
4
lenvatinib
4
Injections
4
Chemotherapy, Adjuvant
4
Bevacizumab
4
sintilimab
3
pembrolizumab
3
Ultrasonography
3
Thalidomide
3
Leucovorin
3
Irinotecan
3
Cisplatin
3
tislelizumab
2
durvalumab
2
camrelizumab
2
anlotinib
2
Walking Speed
2
Standard of Care
2
Radiosurgery
2
Oncolytic Virotherapy
2
Metformin
2
Liver Transplantation
2
Laparoscopy
2
Immunohistochemistry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Liver Neoplasms
×
Platinum Compounds
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled